| abstract |
Described herein are genes whose expression is upregulated or downregulated in prostate cancer. Furthermore, genes whose expression is upregulated or downregulated in drug resistant prostate cancer cells have been described. Related methods and compositions that can be used in the diagnosis and treatment of prostate cancer have been identified. Further described herein are methods that can be used to identify modulators of prostate cancer. |